These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7955001)

  • 1. Neuroleptic malignant syndrome and mivacurium: a safe alternative to succinylcholine?
    Kelly D; Brull SJ
    Can J Anaesth; 1994 Sep; 41(9):845-9. PubMed ID: 7955001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose mivacurium is less effective than succinylcholine in electroconvulsive therapy.
    Cheam EW; Critchley LA; Chui PT; Yap JC; Ha VW
    Can J Anaesth; 1999 Jan; 46(1):49-51. PubMed ID: 10078403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome.
    Addonizio G; Susman VL
    J Clin Psychiatry; 1987 Mar; 48(3):102-5. PubMed ID: 2880837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxacurium and mivacurium do not trigger malignant hyperthermia in susceptible swine.
    Sufit RL; Kreul JF; Bellay YM; Helmer P; Brunson DB; Will J
    Anesth Analg; 1990 Sep; 71(3):285-7. PubMed ID: 2144100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The malignant neuroleptic syndrome and malignant hyperthermia].
    Mitterschiffthaler G; Hackl JM; Neumann R
    Anaesthesist; 1989 Apr; 38(4):210-3. PubMed ID: 2729540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is succinylcholine after pretreatment with d-tubocurarine and lidocaine contraindicated for outpatient anesthesia?
    Mikat-Stevens M; Sukhani R; Pappas AL; Fluder E; Kleinman B; Stevens RA
    Anesth Analg; 2000 Aug; 91(2):312-6. PubMed ID: 10910840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution of mivacurium for succinylcholine for ECT in elderly patients.
    Janis K; Hess J; Fabian JA; Gillis M
    Can J Anaesth; 1995 Jul; 42(7):612-3. PubMed ID: 7553998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different priming techniques, including mivacurium, accelerate the onset of rocuronium.
    Naguib M
    Can J Anaesth; 1994 Oct; 41(10):902-7. PubMed ID: 8001208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rocuronium-sugammadex for electroconvulsive therapy management in neuroleptic malignant syndrome: A case report.
    Casas Reza P; Gestal Vázquez M; Outeiro Rosato Á; López Álvarez S; Diéguez García P
    Rev Esp Anestesiol Reanim; 2017 Feb; 64(2):105-107. PubMed ID: 27424873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimum Effective Doses of Succinylcholine and Rocuronium During Electroconvulsive Therapy: A Prospective, Randomized, Crossover Trial.
    Mirzakhani H; Guchelaar HJ; Welch CA; Cusin C; Doran ME; MacDonald TO; Bittner EA; Eikermann M; Nozari A
    Anesth Analg; 2016 Sep; 123(3):587-96. PubMed ID: 26967896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases.
    Trollor JN; Sachdev PS
    Aust N Z J Psychiatry; 1999 Oct; 33(5):650-9. PubMed ID: 10544988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of tracheal intubating conditions and neuromuscular blocking profiles after intubating doses of mivacurium chloride or succinylcholine in surgical outpatients.
    Goldberg ME; Larijani GE; Azad SS; Sosis M; Seltzer JL; Ascher J; Weakly JN
    Anesth Analg; 1989 Jul; 69(1):93-9. PubMed ID: 2525886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe bradycardia after anesthesia before electroconvulsive therapy.
    Birkenhäger TK; Pluijms EM; Groenland TH; van den Broek WW
    J ECT; 2010 Mar; 26(1):53-4. PubMed ID: 19710620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interaction between mivacurium and succinylcholine from a different point of view].
    Steinberg D
    Rev Esp Anestesiol Reanim; 2006 Mar; 53(3):152-8. PubMed ID: 16671258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rocuronium is the best non-depolarizing relaxant to prevent succinylcholine fasciculations and myalgia.
    Martin R; Carrier J; Pirlet M; Claprood Y; Tétrault JP
    Can J Anaesth; 1998 Jun; 45(6):521-5. PubMed ID: 9669004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hyperthermia: pharmacology of triggering.
    Hopkins PM
    Br J Anaesth; 2011 Jul; 107(1):48-56. PubMed ID: 21624965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapacuronium: an alternative to succinylcholine for electroconvulsive therapy.
    Kadar AG; Kramer BA; Barth MC; White PF
    Anesth Analg; 2001 May; 92(5):1171-2. PubMed ID: 11323342
    [No Abstract]   [Full Text] [Related]  

  • 18. Combinations of high-dose vecuronium and mivacurium provide similar paralysis and intubation conditions to succinylcholine in paediatric patients.
    Theroux MC; Brandom BW; Zagnoev MM; Drago L
    Paediatr Anaesth; 1996; 6(6):453-8. PubMed ID: 8936542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lack of sensitivity to per-anesthetic malignant hyperthermia in 32 patients who developed neuroleptic malignant syndrome].
    Bello N; Adnet P; Saulnier F; Lestavel P; Adnet-Bonte C; Reyford H; Etchrivi T; Tavernier B; Krivosic-Horber R
    Ann Fr Anesth Reanim; 1994; 13(5):663-8. PubMed ID: 7733515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated propofol anesthesia for a patient with a history of neuroleptic malignant syndrome.
    Sakamoto A; Hoshino T; Suzuki H; Kimura M; Ogawa R
    Nihon Ika Daigaku Zasshi; 1999 Aug; 66(4):262-5. PubMed ID: 10466342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.